[Psoriatic arthritis : Drugs of the (near) future].

about

[Psoriatic arthritis : Drugs of the (near) future].

Item

http://www.wikidata.org/entity/Q54998108

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

[Psoriatic arthritis : Drugs of the (near) future].

@en

[Psoriatic arthritis : Drugs of the

@nl

type

Item

label

[Psoriatic arthritis : Drugs of the (near) future].

@en

[Psoriatic arthritis : Drugs of the

@nl

prefLabel

[Psoriatic arthritis : Drugs of the (near) future].

@en

[Psoriatic arthritis : Drugs of the

@nl

P1476

[Psoriatic arthritis : Drugs of the (near) future].

@en

P2093

D Redelstein

http://www.w3.org/2001/XMLSchema#string

M Fleck

http://www.w3.org/2001/XMLSchema#string

P2860

IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding

Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin

Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial.

Back to the future: oral targeted therapy for RA and other autoimmune diseases.

Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial.

Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?

Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate.

The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses.

P2888

s00393-017-0337-x

P304

504-508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00393-017-0337-X

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28681115

http://www.w3.org/2001/XMLSchema#string